HMOX1 and diabetic kidney disease: Additionally, QCT activates the Nrf2/HO-1 signaling pathway by increasing Nrf2 and HO-1 levels, thereby inhibiting ferroptosis in these cells and potentially improving diabetic nephropathy (Feng et al., 2023).